Health ❯ Healthcare ❯ Clinical Trials

Regulatory Affairs

European Medicines Agency FDA Approval FDA Approval Process EU Clinical Trials Register FDA Response Letters European Union Drug Approval Processes FDA Engagement EU Clinical Trials FDA Biologics License Application FDA Approvals EMA Guidelines ANVISA AI in Healthcare FDA and EMA Approval

FDA Rejects Replimune’s Melanoma Virus Therapy Again for Insufficient Evidence

The decision underscores the FDA’s insistence on well‑controlled efficacy data over single‑arm results.

FDA Maps New Paths for Rare-Disease Drug Evidence, Keeps Bar High

FDA Issues Second Rejection of Atara’s EBV+ PTLD Therapy Tabelecleucel

MHRA Reforms and AI Cut UK Clinical Trial Approval Times to 41 Days

Arecor and Sequel to Co-Develop AT278 With Twiist AID for High-Dose Diabetes Care